Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |